These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8551675)

  • 1. [Progress in the diagnosis of endocrine and metabolic disorders: hyperlipidemia].
    Yamashita S
    Rinsho Byori; 1995 Nov; 43(11):1120-7. PubMed ID: 8551675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular genetics of cholesterol transport and cholesterol reverse transport disorders (familial hypercholesterolemia and CETP deficiency), and coronary heart disease].
    Mabuchi H
    Rinsho Byori; 1995 Apr; 43(4):342-6. PubMed ID: 7739114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New approach to pathogenesis of genetic hyperlipoproteinemias].
    Koizumi J; Inazu A; Mabuchi H
    Rinsho Byori; 1993 May; 41(5):519-26. PubMed ID: 8350515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholesteryl ester transfer protein (CETP) deficiency and increased HDL cholesterol levels (hyperalphalipoproteinemia)].
    Inazu A; Koizumi J; Mabuchi H
    Rinsho Byori; 1996 Apr; 44(4):322-6. PubMed ID: 8847813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.
    Miltiadous G; Cariolou MA; Elisaf M
    Ann Clin Lab Sci; 2002; 32(1):50-4. PubMed ID: 11848618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
    Moriyama Y; Okamura T; Inazu A; Doi M; Iso H; Mouri Y; Ishikawa Y; Suzuki H; Iida M; Koizumi J; Mabuchi H; Komachi Y
    Prev Med; 1998; 27(5 Pt 1):659-67. PubMed ID: 9808796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial defective apolipoprotein B-100.
    Hansen PS
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic implications of cholesteryl ester transfer protein inhibitors in hyperlipidemia and low high-density lipoprotein-cholesterolemia.
    Inazu A; Mabuchi H
    Curr Opin Investig Drugs; 2003 Mar; 4(3):291-7. PubMed ID: 12735230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
    Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
    J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
    Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
    Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum apolipoprotein E-rich HDL-C levels in the subjects with hyperalphalipoproteinemia].
    Inano K; Miida T; Okada M
    Rinsho Byori; 1997 Sep; 45(9):903-7. PubMed ID: 9311266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of recurrent and novel mutations in the LDL receptor gene in Japanese familial hypercholesterolemia. Mutation in brief no. 248. Online.
    Hattori H; Nagano M; Iwata F; Homma Y; Egashira T; Okada T
    Hum Mutat; 1999; 14(1):87. PubMed ID: 10447263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary hyperlipidemia in children and adolescents: effects of dietary and pharmacological intervention].
    Muñoz Calvo MT; Argente Oliver J; Cocho Gómez P; Barrios Sabador V; Bonet Serra B; Hernández Rodríguez M
    An Esp Pediatr; 1996 Oct; 45(4):386-92. PubMed ID: 9005726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.